Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: U.S. FDA Places Jubilant Pharmova Facility Under Import Alert At Roorkee

July 15 (Reuters) - Jubilant Pharmova Ltd  JUBA.NS :
    * USFDA HAS PLACED FACILITY UNDER IMPORT ALERT AT ROORKEE
    * PRODUCTS THAT GET IMPACTED DUE TO IMPORT ALERT CONTRIBUTED
TO
LESS THAN 3% OF FY21 TOTAL REVENUES
    * IMPORT ALERT IN RESPONSE TO FDA INSPECTION CONDUCTED AT
DOSAGE
FORMULATIONS FACILITY AT ROORKEE DURING MARCH 2021
    * FDA HAS EXEMPTED CERTAIN PRODUCTS INCLUDING VALSARTAN
TABLETS
FROM IMPORT ALERT 

Source text for Eikon:  ID:nBSEVLFWj 
Further company coverage:  JUBA.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Jubilant Pharmova

See all news